Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in ItalyAda Bertoli, Alessia Ciancio, Pierluigi Cacciatore et al.|Scientific Reports|2018Cited by 48
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?Velia Chiara Di Maio, L. Lambiase, Valeria Cento et al.|Journal of Hepatology|2017Cited by 31
Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experienceMatteo Passerini, Giuliano Rizzardini, Monica Schiavini et al.|European Journal of Gastroenterology & Hepatology|2018Cited by 24
Breast Hypertrophy Induced by Ombitasvir/Paritaprevir/Ritonavir and RibavirinaMarta Gentili, Sonia Radice, C. Magni et al.|The Breast Journal|2016Cited by 3
Direct Acting Antivirals in patients with HCV-associated mixed cryoglobulinemia: real life safety and efficacyGiuliano Rizzardini, G. Gubertini, Monica Schiavini et al.|Journal of Hepatology|2017Cited by 0